Advertisements

Бициллин-3

Quick links to important sections

Бициллин-3

Advertisements
Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Бициллин-3

Quick Facts

Property Description
Active Ingredients Benzylpenicillin Sodium, Benzylpenicillin Procaine, Benzylpenicillin Benzathine
Form Lyophilizate (powder) for injectable suspension
Pharmacological Class Beta-lactam antibiotic, Natural Penicillin Group
Common Use (General) Treating bacterial infections; long-term prophylaxis
Type Combination, Sustained-release (repository)

The Pharmacological Identity and Class of Bicillin-3

Bicillin-3 (Бициллин-3) is a combination product belonging to the beta-lactam antibiotic class, specifically categorized within the natural penicillin group. Its core active component, Benzylpenicillin (Penicillin G), is utilized for its effectiveness against susceptible bacteria and is classified as a prescription-only (Rx) medicine. This specific formulation characterizes Bicillin-3 as a sustained-release antimicrobial agent, designed to achieve prolonged therapeutic concentrations in the body, which reduces the frequency of required dosing.


Composition and Unique Long-Acting Form

The pharmaceutical preparation of Bicillin-3 consists of a mixture of three distinct Benzylpenicillin salts: a rapidly soluble sodium salt and two less soluble depot forms—Benzylpenicillin Procaine and Benzylpenicillin Benzathine. The product is supplied as a lyophilizate (powder) intended for preparation as an injectable suspension administered via the intramuscular route.

The presence of the depot salts, Procaine and Benzathine, allows for the gradual absorption of the medication from the muscle tissue, creating a reservoir for steady release. This mechanism is essential for maintaining drug levels in the bloodstream over an extended period. Additionally, the Procaine component provides a localized anesthetic effect, which can help mitigate the immediate discomfort often associated with deep intramuscular injections.


General Purpose of Repository Penicillin Agents

The primary purpose of Bicillin-3 is to provide a long-acting effect by maintaining effective antimicrobial concentrations for a duration longer than standard penicillin. This repository penicillin design is intended for clinical scenarios that require consistent drug exposure over several days, such as the management of specific infections or preventing their recurrence. In practice, this delivery method is used to support the eradication of bacterial infections and to provide long-term prophylaxis when continuous antibiotic coverage is necessary.

Advertisements

What side effects are possible with Бициллин-3?

The official safety profile for Бициллин-3 (a combination of Benzylpenicillin salts) is defined by government regulatory documents, focusing on risks common to penicillins and those specific to its injection route. All factual safety statements are based on mandated labeling from authoritative health agencies.


Adverse Reaction Scope

The most significant risks involve Hypersensitivity Reactions, which can manifest as immediate and life-threatening Anaphylaxis, or delayed reactions like Severe Cutaneous Adverse Reactions (SCAR) such as Stevens-Johnson Syndrome (SJS). The official classification for the frequency of many serious effects is often Incidence not known, relying on post-marketing surveillance data.

Adverse events are formally grouped by System-Organ Classes, including Nervous System Disorders (e.g., Procaine-related reactions like Hoigne's syndrome, seizures), Gastrointestinal Disorders (e.g., antibiotic-associated Clostridium difficile-associated diarrhea [CDAD]), and Blood and Lymphatic System Disorders.


Serious and Unique Safety Considerations

A critical, documented risk is related to the required deep intramuscular injection. Inadvertent administration into or near a nerve or artery can lead to severe neurovascular damage, potentially resulting in necrosis, gangrene, or permanent paralysis.

Time-related patterns are noted for certain reactions: the Jarisch-Herxheimer Reaction may occur shortly after treatment initiation for spirochetal infections, while CDAD can appear during therapy or up to two months after discontinuation.

Safety Constraints and Contraindications include a strict prohibition against use in patients with a history of hypersensitivity to any penicillin or to Procaine. Furthermore, the formulation is strictly not for intravenous (IV) use due to the severe cardiopulmonary and neurovascular risks documented with this route of administration.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Bicillin-3 (a Benzylpenicillin combination) is officially documented to carry the potential for serious neurological and systemic manifestations resulting from excessively high penicillin concentrations.

Manifestation Category Documented Clinical Signs
CNS/Neurological Convulsive seizures, neuromuscular hyperirritability, severe agitation with confusion, hallucinations, psychosis, and dizziness.
Systemic/Cardio Palpitations, tachycardia, and cyanosis are noted, along with the potential for electrolyte imbalance.

A severe outcome noted in official documents is neurotoxicity, a risk that is significantly heightened in patients with impaired renal function due to reduced clearance, which can lead to toxic serum levels. Laboratory findings associated with overdose include elevated BUN and creatinine.

The official response requires immediate discontinuation of the medicinal product. Management is strictly symptomatic and supportive, as regulatory agencies state that no specific antidote is known for penicillin overdose. Immediate medical attention or contacting emergency services is mandated if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Advertisements

Therapeutic Uses of Бициллин-3

This medication is commonly used across domains where additional symptomatic support is needed, primarily within three key therapeutic areas. The therapeutic uses for this type of medication are aligned with established medical guidelines regarding conditions with significant symptom expression. The treatment is applied in clinical settings involving acute or unstable symptom patterns caused by susceptible streptococci and is used for symptomatic support in conditions such as pharyngitis, scarlet fever, and erysipelas.

It is also relevant for easing symptoms associated with conditions involving episodic or fluctuating manifestations. It is utilized in scenarios where short-term symptom stabilization is important for secondary prophylaxis to support the avoidance of complications like acute rheumatic fever and acute glomerulonephritis. Furthermore, it is applied in addressing infection in contexts that require thorough therapeutic support for spirochetal conditions, including syphilis. This approach provides support that helps ease the overall symptom burden during symptomatic periods.


Quick Fact: Symptomatic Support Focus Area of Use Symptoms Addressed (Examples) Supportive Benefit
Acute Infection Fever, malaise, local inflammation, sore throat Contributes to improved comfort during symptomatic periods.
Long-Term Protection Risk of joint pain or cardiac inflammation sequelae May assist with maintaining functional stability over time.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Бициллин-3

Eligibility for Бициллин-3 is strictly defined by regulatory documents, focusing on patient history and the drug's specialized formulation.

Contraindications and Restrictions

Classification Rule (Official Regulatory Statement)
Absolute Contraindication Patients with a confirmed history of allergy to any penicillin or to the procaine component must not use this medicine. It is also contraindicated in those with a severe reaction to other beta-lactam antibiotics (e.g., cephalosporins).
Prohibited Use Administration via the intravenous (IV) or intra-arterial route is strictly prohibited. The medicine is also not recommended for treating neurosyphilis due to its low concentration in the cerebrospinal fluid.

Conditional Use and Special Populations

  • Age Groups: Use is established for adults and pediatric patients, including infants and neonates. Caution is required when determining the dosage for older adults (65+) due to the higher likelihood of decreased kidney, liver, or heart function.
  • Organ Function: Patients with impaired renal function require cautious use and monitoring, as the drug’s elimination may be delayed.
  • Pregnancy and Lactation: Use is permitted during pregnancy when clearly indicated, and it is the standard treatment for certain infections in this population. Caution is advised when administering to nursing mothers.
Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section summarizes the officially documented interactions for Бициллин-3 (a Benzylpenicillin combination), based strictly on information found in government regulatory prescribing documents.

Documented Interaction Patterns

The primary interactions involving Benzylpenicillin are related to its excretion and its antimicrobial activity. Certain drug combinations may alter the amount of penicillin in the bloodstream or interfere with its therapeutic effect.

Interacting Product Category Official Effect Description Classification/Restriction
Probenecid and NSAIDs Increases Benzylpenicillin plasma concentrations and half-life. Potential for Increased Exposure
Tetracyclines (Bacteriostatic Agents) May lead to an antagonistic effect on penicillin's bactericidal action. Combination Generally Not Recommended
Oral Contraceptives Potential to reduce the effectiveness of hormone-based contraceptives. Caution/Alternative Method Advised

Exposure-Modifying Interactions

Probenecid and non-steroidal anti-inflammatory drugs (NSAIDs) are officially documented to decrease the renal tubular secretion of penicillin G. This effect is a pharmacokinetic interaction that results in higher and more prolonged exposure to the active antibiotic component.

Population-Specific Constraints

For patients with renal impairment (kidney disease), official information notes that the excretion of penicillin G is considerably delayed. This pre-existing condition, which slows the drug's clearance, can result in increased systemic exposure, which is an important consideration noted in regulatory labeling.

Advertisements

Mechanism of Action

The mechanism of Бициллин-3 is a highly specific bactericidal action aimed at destroying the structural integrity of susceptible bacteria, achieved through a unique formulation which modulates the duration of active molecule release.

Covalent Blockade of Bacterial Cell Wall Synthesis

The primary mechanism involves the irreversible covalent inhibition of bacterial Penicillin-Binding Proteins (PBPs), which are enzymes essential for forming the rigid peptidoglycan cell wall. Benzylpenicillin G acts as a structural decoy, binding permanently to the PBP active site and halting the cross-linking process. This molecular interference activates bacterial autolytic enzymes, leading to the catastrophic lysis of the cell wall and the subsequent systemic reduction of susceptible bacterial load.

Temporal Modulation of Mechanistic Exposure

The drug utilizes a combination of three salts (Sodium/Potassium, Procaine, and Benzathine) to achieve a controlled onset and duration of the mechanism. The rapidly soluble salt provides immediate exposure to the active Penicillin G to quickly initiate PBP inhibition, while the two less-soluble salts form a depot reservoir. This complementary mechanism modulates release kinetics to maintain the bactericidal concentration above the minimum inhibitory concentration (MIC) for an extended duration, contributing to a prolonged duration of PBP inhibition.

Localized Modulation of Sensory Nerves

A separate, complementary action is provided by the Procaine component, which acts as a local anesthetic. Its mechanism is the transient blockade of voltage-gated sodium channels on local peripheral nerve endings. This action interrupts the transmission of pain signals, resulting in localized interruption of nociceptive signal transmission that is tied directly to the high-volume intramuscular administration of the depot formulation.

Advertisements

Dosage and Administration Information

How to Use Бициллин-3 (Benzathine Benzylpenicillin G Suspension)

This section outlines the administration procedure and dosing for the active constituent, Benzathine Benzylpenicillin G.


Administration Procedure

Бициллин-3 (a combination of Benzathine, Procaine, and Benzylpenicillin) is administered only via deep intramuscular (IM) injection. It must NEVER be injected intravenously (IV), subcutaneously (SC), or intrathecally (IT), as this can lead to severe adverse events.

Preparation Steps:

  1. The powder must be reconstituted with the specified sterile diluent (e.g., Water for Injections) immediately before use, forming a uniform suspension.
  2. The reconstituted product should be visually inspected; it must not be used if particulate matter or discoloration is observed.
  3. Warm the suspension to room temperature before injection to facilitate a slower, less painful administration.

Injection Technique:

  • Use the upper-outer quadrant of the buttock (dorsogluteal) or the ventrogluteal site in adults and older children. For infants and small children, the mid-lateral thigh may be used.
  • The needle must be inserted deeply, and aspiration must be performed before injection to ensure a blood vessel has not been entered. If blood is aspirated, the injection must be withdrawn and the site changed.
  • The suspension must be injected slowly and steadily to minimize pain and prevent needle blockage. If the total dose exceeds 1.2 million IU, the reconstituted volume is typically divided and injected into two separate sites.

Official Dosing Schedule

The frequency is highly dependent on the condition being treated, ranging from a single dose to a monthly schedule for prophylaxis.

Condition Typical Dosage (Adults & Adolescents) Frequency
Rheumatic Fever Prophylaxis 1.2 million IU Every 3 to 4 weeks
Early Syphilis 2.4 million IU Single dose
Late/Latent Syphilis 2.4 million IU Once weekly for 3 weeks
  • Pediatric Dosing: For children, the dose is often weight-based or age-specific, and an alternate site (mid-lateral thigh) may be necessary for administration.
Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies for Бициллин-3 (Repository Penicillin)

Research for repository Benzylpenicillin, which includes the combination found in Bicillin-3, has been gathered over decades and is relevant for conditions where maintaining drug levels over time has been studied. The findings describe group patterns observed in studies and provide context but not individual predictions.


Evidence for Use in Acute Group A Streptococcal (GAS) Infections

Research examining the use of long-acting penicillin for acute Group A Streptococcal (GAS) infections, such as pharyngitis, includes short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies primarily focused on children and adolescents, comparing the single injection to multi-day courses of oral antibiotics. Researchers explored outcomes related to the microbiological eradication of the target bacteria and the clinical resolution of outcomes related to physical discomfort.

Studies report how symptoms evolved in the observed populations, and findings describe patterns observed in the eradication rates of the bacteria following treatment. What remains uncertain is the quality of reporting in some of the older comparative trials, and comparative evidence is lacking against some of the newer oral antibiotics used today.


Evidence for Use in Secondary Prophylaxis of Acute Rheumatic Fever (ARF)

The research exploring the use of repository penicillin for the secondary prevention of Acute Rheumatic Fever (ARF) relies largely on long-term cohort studies and meta-analyses. These studies monitored pediatric and young adult populations over extended periods. The evidence was evaluated in studies examining outcomes related to the frequency of ARF recurrence and patient adherence to the scheduled injections.

Studies describe the observed association between maintaining the scheduled injections and the prevention of ARF recurrence. The main uncertainty noted is that while the treatment is well-established, long-term effects are not fully established concerning the progression of existing cardiac damage over a patient's lifetime. Also, adherence rates were observed in some studies to be very low in real-world settings.


Evidence for Use in Syphilis (Spirochetal Infection)

The use of repository penicillin for treating syphilis was evaluated in RCTs comparing different treatment schedules for early-stage disease, as well as systematic reviews and observational evidence for late-stage or latent syphilis. Studies monitored the serological response (a measured decline in blood marker levels) with follow-up periods of up to two years. Subgroup findings are uncertain concerning the optimal dosing strategies for all complex patient populations, such as those with HIV co-infection, and research is ongoing in these areas.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Бициллин-3 (FAQ)


Q: How long does the medicine stay active in the body after one injection?

Official product information indicates that detectable concentrations of the drug can remain in the bloodstream for 14 days or longer following a single injection. Lower concentrations may persist for up to four weeks. This prolonged presence is due to the drug’s specialized long-acting formulation.


Q: Does Бициллин-3 treat infections differently than standard oral antibiotics?

The drug is noted to have a different administration and absorption profile compared to standard oral antibiotics. Regulatory documents describe it as a long-acting suspension that is released slowly from the deep muscle injection site. This mechanism produces drug levels that are lower but are maintained for a significantly more prolonged period than those achieved with many other injectable or oral penicillins.


Q: Why is the injection form necessary instead of a tablet or pill?

The active components of this formulation, primarily Benzathine Benzylpenicillin G, are naturally poorly absorbed when taken by mouth and are highly susceptible to being broken down by stomach acid. The deep intramuscular injection is necessary to establish a depot reservoir in the muscle, which facilitates the gradual and prolonged absorption of the medication into the bloodstream.


Q: What does the number '3' in the name Бициллин-3 actually refer to?

The number '3' in the name refers to the fact that this specific product contains a combination of three distinct salts of Benzylpenicillin. These salts—Benzathine, Procaine, and Potassium/Sodium Benzylpenicillin—are mixed together to control the rate at which the active medicine is released into the body.


Q: Is it true that this drug is only indicated for conditions like syphilis and certain types of strep throat?

Official regulatory documents confirm that this drug is indicated for specific infections. These include certain venereal infections (like Syphilis, yaws, bejel, and pinta) and infections caused by susceptible streptococci, such as mild-to-moderate upper-respiratory tract infections. It is also indicated for the long-term prophylaxis (prevention) of Rheumatic fever.


Q: Why does the injection only need to be given once in many cases?

The Benzathine component of the injection is designed with extremely low solubility. This mechanism causes the drug to be released very slowly from the muscle tissue, effectively creating a long-lasting drug reservoir. This prolonged release allows drug concentrations to be maintained for an extended period, which can reduce the frequency of administration compared to other antibiotics.


Q: How painful is the Бициллин-3 injection really, based on user experience?

Official product information indicates that pain and tenderness at the injection site are frequently reported adverse effects. To counteract this, the formulation includes Procaine as a local anesthetic to help reduce the immediate discomfort associated with the necessary deep intramuscular injection.


Q: Is it normal for the injection site to hurt or feel stiff for several days after the shot?

Official documentation describes injection site reactions as reported adverse effects. These can include pain, inflammation, swelling, and sometimes the formation of a lump or mass at the injection area. These reactions may persist beyond the initial injection itself.


Q: How long after the injection can a person still experience an allergic reaction?

While some allergic reactions can be immediate, regulatory warnings indicate that delayed reactions have also been reported. Severe Cutaneous Adverse Reactions (SCAR) can sometimes develop weeks to months after treatment initiation. Also, antibiotic-associated diarrhea can sometimes appear up to two months or more after the medication has been stopped.


Q: Are there any widely known methods to help lessen the intensity of the injection pain?

The medication includes the anesthetic Procaine to assist with immediate pain relief. Furthermore, official administration techniques, such as injecting the suspension slowly and steadily and warming the suspension to room temperature before use, are known methods intended to minimize the discomfort of the deep injection.


Q: Are severe, life-threatening side effects common with Бициллин-3?

Official regulatory warnings highlight that serious and occasionally fatal hypersensitivity (Anaphylactic) reactions have been reported. These severe reactions are noted to carry an increased risk in individuals who have a pre-existing history of penicillin allergy or who are sensitive to multiple allergens.


Q: Does this antibiotic disrupt the body's natural immune system or gut flora?

Official safety information states that treatment with antibacterial agents alters the normal flora of the colon. This change can potentially lead to an overgrowth of certain bacteria, which may result in severe diarrhea known as Clostridioides difficile-associated diarrhea (CDAD).


Q: Can receiving the shot cause temporary symptoms like a low-grade fever or joint aches?

Yes, regulatory information indicates that temporary symptoms such as fever, chills, muscle aches, and joint pain can be associated with a Jarisch-Herxheimer reaction. This reaction may occur a few hours after starting treatment for spirochetal infections, such as syphilis.


Q: Does this medicine cause long-term side effects such as fatigue or muscle weakness?

Official adverse reaction lists include general symptoms such as unusual tiredness, muscle pain, and muscle weakness among the noted adverse effects. However, regulatory documents do not specifically define these symptoms as being 'long-term' effects of the medication.


Q: What is the difference between a common side effect and a sign of an allergic reaction?

Allergic reactions are distinct from common side effects; they are described as involving the immune system and can present as signs such as hives, rash, itching, swelling of the face/throat, or difficulty breathing. Regulatory warnings stress that these allergic signs are considered serious. Other symptoms like headache or nausea are listed as adverse effects of unknown frequency.


Q: Is it safe to be around other people immediately after receiving this injection?

This medication is an antibacterial agent and is not associated with being contagious. Official guidance indicates there is no information or requirement for patient isolation after administration.


Q: How quickly does the body typically begin to feel better after the injection is given?

The time it takes to feel better depends heavily on the specific infection being treated. For example, for infections like syphilis, official treatment guidelines indicate that symptoms like sores or rashes typically take between 2–4 weeks to disappear after treatment.


Q: Is there a waiting period before the effects of Бициллин-3 are fully realized?

Yes. Since the drug is released slowly from the muscle reservoir, it typically takes several hours to achieve the peak concentration in the blood. This peak concentration is necessary for the medication's full therapeutic effect to be realized.


Q: Should I expect to feel tired or unusually sleepy after receiving the injection?

Official product information lists sleepiness (somnolence) or unusual drowsiness as a reported adverse effect of the medication.


Q: Does the consistency or thickness of the medication contribute to the pain of the shot?

Yes, official documents describe the Benzathine penicillin component as an opaque and viscous suspension with very low solubility. This physical characteristic is officially recognized as a factor contributing to the painful nature of the required deep intramuscular injection.


Q: What is the Jarisch-Herxheimer reaction that is sometimes mentioned with this drug?

The Jarisch-Herxheimer reaction is an official safety consideration associated with spirochete infections like syphilis. It is a sudden, usually temporary, inflammatory response that may occur within 24 hours of starting antibiotic therapy. Symptoms commonly include fever, chills, headache, and muscle aches.


Q: Can people with a history of asthma or seasonal allergies use this medicine safely?

Official product warnings indicate that caution is advised for use in individuals who have a history of significant allergies or asthma. This is because those individuals may have an increased potential risk for experiencing adverse effects.


Q: Can people who are allergic to certain foods still get the shot?

Official guidance emphasizes the importance of providing a complete history of all known allergies, including sensitivities to foods, dyes, or preservatives. This is because a history of sensitivity to multiple allergens may increase the potential risk of a severe allergic reaction to the medication itself.


Q: Can I drink alcohol while the medicine is active in my body?

Official drug labels generally do not specifically address alcohol consumption with this medication. Standard clinical practice involves reviewing a patient's complete history, including any alcohol intake, to identify potential interactions with the medicine or the underlying medical condition being treated.


Q: Are there any specific vitamins, herbal supplements, or products that should be avoided with Бициллин-3?

Official guidance notes that the complete listing of all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products is important. This is because some supplements may cause interactions that could change how the medication works in the body.


Q: What is the difference between Bicillin L-A and Bicillin C-R?

Official regulatory documents differentiate these products based on their active components. Bicillin L-A contains only Benzathine Penicillin G, which is the long-acting salt. Bicillin C-R contains a combination of Benzathine Penicillin G and Procaine Penicillin G, which gives it a different, more intermediate-acting profile.


Q: Is Бициллин-3 used in countries outside of Russia/former Soviet states?

The active component, Benzathine Benzylpenicillin G, is used globally for the same medical indications. While the brand name Бициллин-3 may be specific to certain regions, the formulation of long-acting penicillin is used worldwide under different brand names, such as Bicillin L-A in the US.

Advertisements

How should Бициллин-3 be stored and disposed of?

How to Store and Dispose of Бициллин-3

The storage of the unreconstituted dry powder for injectable suspension must adhere strictly to regulatory requirements to ensure product stability.

Storage Conditions

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature, mathbf20 C to mathbf25 C (mathbf68 F to mathbf77 F).
Protection Must be protected from freezing, moisture, and light.
Container Keep in the original container and maintain it tightly closed.
Child Safety Keep out of the sight and reach of children.

The regulatory guidance indicates that the constituted suspension is intended for immediate use due to its limited stability.

Disposal Instructions

Unused or expired Бициллин-3 must not be disposed of via wastewater or routine household trash, as mandated by official pharmaceutical waste guidelines. Disposal must be carried out according to local requirements and established procedures for unused medicinal products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Бициллин-3 found in:

A-Z Index: